Sorted By:

Relevance


For a Healthier America: PhRMA's Public Policy Strategy to Combat the Opioid Crisis

PhRMA  |  Policy Paper

PhRMA and its members are committed to working with other stakeholders to collectively address this growing public health crisis.
https://www.phrma.org/policy-paper/for-a-healthier-america-phrma-s-public-policy-strategy-to-combat-the-opioid-crisis

PhRMA Statement Following Meeting With HHS Secretary Price

PhRMA  |  Press Release

Connect with PhRMA For information on how innovative medicines save lives, please visit: www.PhRMA.org www.Innovation.org www.GoBoldly.com www.Facebook.com/PhRMA www.Twitter.com/PhRMA
https://www.phrma.org

Patient Profile: How Medicare Part D Extra Help Works - Mateo

PhRMA  |  Graphic

He does this with the help of his Medicare Part D prescription drug coverage. 
https://www.phrma.org/graphic/patient-profile-how-medicare-part-d-extra-help-works-mateo

PhRMA Calls for Repeal of the Ensuring Patient Access and Effective Drug Enforcement Act of 2016

PhRMA  |  Press Release

Connect with PhRMAFor information on how innovative medicines save lives, please visit:  www.PhRMA.org .innovation.org/?
https://www.phrma.org/press-release/phrma-calls-for-repeal-of-the-ensuring-patient-access-and-effective-drug-enforcement-act-of-2016

Partnership for Prescription Assistance Adds New Feature to Website to Help America’s Uninsured Access Information about Medicaid and CHIP

PhRMA  |  Press Release

Our goal is simple: we want to help ensure that all Americans have access to high-quality and affordable healthcare coverage,” Tauzin said.
https://www.phrma.org/press-release/partnership-for-prescription-assistance-adds-new-feature-to-website-to-help-america-s-uninsured-access-information-about-medicaid-and-chip

340B Spotlight: ICYMI – 340B hearing, new reports highlight growing need for program reform

PhRMA  |  Blog Post

It’s time for Congress and the Administration to fix this program.
http://catalyst.phrma.org/340b-spotlight-icymi-340b-hearing-new-reports-highlight-growing-need-for-program-reform

Value-Based Contracting for Oncology Drugs: A NEHI White Paper

PhRMA  |  Report

This white paper from the Network for Excellence in Health Innovation (NEHI) outlines barriers to these outcomes-based contracts and highlights regulatory steps that would enable new payment arrangements for high-cost cancer treatments.  
https://www.phrma.org/report/value-based-contracting-for-oncology-drugs-a-nehi-white-paper

Burden on Patients: 5 Questions on Access to HIV/AIDS Medicines in Health Exchange Plans

PhRMA  |  Blog Post

HIV is very unique and every patient has different needs.
http://catalyst.phrma.org/burden-on-patients-5-questions-on-access-to-hiv/aids-medicines-in-health-exchange-plans

Prescription Drug Lifecycle Helps Health Care Spending Hit Record Low

PhRMA  |  Blog Post

Get updates on this subject and/or other relevant issues here. 
http://catalyst.phrma.org/prescription-drug-lifecycle-helps-health-care-spending-hit-record-low

I’m Not Average Campaign Hits Close to Home

PhRMA  |  Blog Post

Today, cancer survival rates are higher than ever thanks to advances in treatment options.
http://catalyst.phrma.org/im-not-average-campaign-hits-close-to-home

New analysis: More than half of patients’ out-of-pocket spending for brand medicines is based on full list price

PhRMA  |  Blog Post

Read the full analysis here.
http://catalyst.phrma.org/new-analysis-more-than-half-of-patients-out-of-pocket-spending-for-brand-medicines-is-based-on-full-list-price

New Data Show More Than Half of Patients’ Out-of-Pocket Spending for Brand Medicines Is Based on List Price

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than half a trillion dollars in the search for new treatments and cures, including an estimated $58.8 billion in 2015 alone.
https://www.phrma.org/press-release/new-data-show-more-than-half-of-patients-out-of-pocket-spending-for-brand-medicines-is-based-on-list-price

ICYMI: Survey highlights key barriers limiting number and scale of new approaches to paying for medicines

PhRMA  |  Blog Post

Improve capability for measurement through initiatives that make it easier for stakeholders to track outcomes across the health system, prioritizing measurement of factors that matter most to patients.
http://catalyst.phrma.org/icymi-survey-highlights-key-barriers-limiting-number-and-scale-of-new-approaches-to-paying-for-medicines

ICYMI: Survey highlights key barriers limiting number and scale of new approaches to paying for medicines

PhRMA  |  Blog Post

Improve capability for measurement through initiatives that make it easier for stakeholders to track outcomes across the health system, prioritizing measurement of factors that matter most to patients.
http://catalyst.phrma.org/icymi-survey-highlights-key-barriers-limiting-number-and-scale-of-new-approaches-to-paying-for-medicines

Fighting High Cholesterol

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/fighting-high-cholesterol

Fighting High Cholesterol

PhRMA  |  Blog Post

In 2007, for the first time in 50 years, the average cholesterol level for American adults was within the ideal range, largely as a result of cholesterol-lowering medicine use by those over 60.
http://catalyst.phrma.org/fighting-high-cholesterol

Key U.S. Health Industries Outline Six-Point Plan for Improved Health and Economic Growth in Asia-Pacific Region

PhRMA  |  Press Release

Our industries are poised to help APEC define the future health care needs and demands of this rapidly growing region,” said Joseph Damond, Senior Vice President for International Affairs at BIO.
https://www.phrma.org/press-release/key-u-s-health-industries-outline-six-point-plan-for-improved-health-and-economic-growth-in-asia-pacific-region

New nonprofit – I-ACT for Children – launches to promote innovative medicines development for young patients in need

PhRMA  |  Blog Post

Food and Drug Administration added, “The launch of I-ACT for Children is an important milestone in the global effort to collect reliable data and accelerate treatment development for our pediatric patients.
http://catalyst.phrma.org/new-nonprofit-i-act-for-children-launched-to-promote-innovative-medicines-development-for-young-patients-in-need

PDUFA VI Supports the Advancement of Medicines for Pediatric Patients

PhRMA  |  Fact Sheet

For 25 years, the Prescription Drug User Fee Act (PDUFA) has provided FDA with stable, predictable funding that has resulted in significantly shortened drug review times, greater consistency and predictability, while preserving FDA’s “gold standard” for safety and effectiveness.
https://www.phrma.org

How New Drugs Helping Millions Of Americans Live Longer Are Also Making Them Go Broke

Access Better Coverage  |  From Our Network

” Those working with HIV positive people say they have seen this phenomenon in action.
http://www.accessbettercoverage.org/social-news/how-new-drugs-helping-millions-of-americans-live-longer-are-also-making-them-go-broke

How Cancer Will Affect Americans In 2016

From Hope To Cures  |  From Our Network

For some cancers, the change has been remarkable.
http://www.fromhopetocures.org/how-cancer-will-affect-americans-in-2016

How do multiple sclerosis patients define value?

PhRMA  |  Blog Post

While this information is useful to payers, it fails to acknowledge the costs that matter to patients.
http://catalyst.phrma.org/how-do-multiple-sclerosis-patients-define-value

PhRMA to Present the 2017 Research & Hope Awards for Outstanding Mental Health Advocacy and Research

PhRMA  |  Press Release

Connect with PhRMAFor information on how innovative medicines save lives, please visit:  www.PhRMA.org .innovation.org/?
https://www.phrma.org/press-release/phrma-to-present-the-2017-research-and-hope-awards-for-outstanding-mental-health-advocacy-and-research

Ask About Adherence: One tool for synchronizing and simplifying your medication routine

PhRMA  |  Blog Post

Here are some additional resources to check out to learn more about the importance of medication adherence and see if a program like med sync is right for you and your family.
http://catalyst.phrma.org/ask-about-adherence-one-tool-for-synchronizing-and-simplifying-your-medication-routine

BIO/PhRMA Principles on Responsible Sharing of Truthful and Non-Misleading Information about Medicines with Health Care Professionals and Payers

PhRMA  |  Codes & Guidelines

The Principles pertain primarily to data and information outside of FDA-approved labeling, and are intended to establish responsible, science-based parameters for accurate and trusted information sharing.
https://www.phrma.org/codes-and-guidelines/bio/phrma-principles-on-responsible-sharing-of-truthful-and-non-misleading-information-about-medicines-with-health-care-professionals-and-payers

You have reviewed the first 175 results out of 2565. Each page contains 25 results. You're on page 7.

prev 7 8 9 10 11 12 next